INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES

🇵🇹Portugal
Ownership
-
Employees
-
Market Cap
-
Website

Impact of Physical Activity in Vascular Cognitive Impairment ( AFIVASC )

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-07-06
Last Posted Date
2021-04-01
Lead Sponsor
Instituto de Medicina Molecular João Lobo Antunes
Target Recruit Count
104
Registration Number
NCT03578614
Locations
🇵🇹

Instituto de Medicina Molecular João Lobo Antunes, Lisboa, Portugal

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

First Posted Date
2015-03-11
Last Posted Date
2018-03-06
Lead Sponsor
Instituto de Medicina Molecular João Lobo Antunes
Target Recruit Count
22
Registration Number
NCT02385019
Locations
🇵🇹

Instituto Portugues de Oncologia, Porto, Portugal

🇵🇹

Hospital de Santa Maria, Faculdade de Medicina da Universidade de Lisboa, Instituto de Medicina Molecular, Lisboa, Portugal

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

First Posted Date
2014-02-19
Last Posted Date
2020-11-13
Lead Sponsor
Instituto de Medicina Molecular João Lobo Antunes
Target Recruit Count
44
Registration Number
NCT02065713
Locations
🇵🇹

Centro Académico de Medicina de Lisboa, Lisbon, Portugal

Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis

First Posted Date
2011-08-16
Last Posted Date
2016-03-21
Lead Sponsor
Instituto de Medicina Molecular João Lobo Antunes
Target Recruit Count
101
Registration Number
NCT01417455
Locations
🇵🇹

Instituto de Medicina Molecular, Lisbon, Portugal

© Copyright 2024. All Rights Reserved by MedPath